Bernd Gänsbacher

Technical University of Munich — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

45h-index6.9kcitations171works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(76), CAR-T cell therapy research(40), Immunotherapy and Immune Responses(39), Immune Cell Function and Interaction(27), RNA Interference and Gene Delivery(22)

Publications170 total

A comparison of medical education in Germany and the United States: from applying to medical school to the beginnings of residency
PubMed·2017· 89 citedOpen Access
Clinical Development and Commercialization of Advanced Therapy Medicinal Products in the European Union: How Are the Product Pipeline and Regulatory Framework Evolving?
Human Gene Therapy Clinical Development·2017· 54 cited
A5-3 Tumor imaging with adenoviral vectors
2012
C3-3 CliniGene and ESGCT shared vision for gene therapy in Europe: past, present and future prospects
2012· 1 cited
C3-2 Database of clinical trials
2012
C3-3 CliniGene and ESGCT shared vision for gene therapy in Europe: past, present and future prospects
2012
C3-2 Database of clinical trials
2012
A5-3 Tumor imaging with adenoviral vectors
2012
Effects of cold atmospheric plasmas on adenoviruses in solution
2012· 17 cited
CliniGene and Gene Therapy in Europe: Past, Present & Future Prospects
2012
Optimizing Adenoviral Transduction of Endothelial Cells under Flow Conditions
Pharmaceutical Research·2011· 5 cited
Effects of cold atmospheric plasmas on adenoviruses in solution
Journal of Physics D Applied Physics·2011· 149 cited
YB‐1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma
International Journal of Cancer·2010· 33 citedOpen Access
Erniedrigte Knochendichte bei Männern nicht mit angiographisch nachgewiesener koronarer Herzerkrankung assoziiert
Journal für Kardiologie (Krause & Pachernegg GmbH)·2010Open Access
Prostate Cancer Gene Therapy: Attempts to Innovate
Human Gene Therapy·2010· 6 cited
Tetracycline‐regulated bone morphogenetic protein 2 gene expression in lentivirally transduced primary rabbit chondrocytes for treatment of cartilage defects
Arthritis & Rheumatism·2010· 33 cited
Tissue inhibitor of metalloproteinases‐1‐induced scattered liver metastasis is mediated by host‐derived urokinase‐type plasminogen activator
Journal of Cellular and Molecular Medicine·2009· 20 citedOpen Access
Tissue Engineering of the Anterior Cruciate Ligament—Sodium Dodecyl Sulfate-Acellularized and Revitalized Tendons Are Inferior to Native Tendons
Tissue Engineering Part A·2009· 34 cited
Cancer Gene Therapy: Present and Future
Human Gene Therapy·2009· 2 cited
Therapeutic Vaccination with an Interleukin-2–Interferon-γ-Secreting Allogeneic Tumor Vaccine in Patients with Progressive Castration-Resistant Prostate Cancer: A Phase I/II Trial
Human Gene Therapy·2009· 21 cited
page 1 of 9Next →

Frequent Co-authors

Martina Anton(9), Eli Gilboa(9), Achim Krüger(7), Per Sonne Holm(7), Karen S. Zier(6), Rajat Bannerji(6), Markus Schwaiger(6), Hermann Lage(5), Klaus Mantwill(5), Roland Haubner(5), Frank M. Bengel(4), Riccardo E. Giunta(4), Thomas Holzbach(4), Christian Plank(3), Kathy A. Cronin(3), Felicia M. Rosenthal(3), Charlotte Kopitz(3), Viktor Magdolen(3), Karsten Jürchott(3), T. Brill(3)